humanitarian

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 20, 2026 · 14:52 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised14:52 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 7, Status: Authorised14:52 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 19, Status: Autho…14:36 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 19, Status: Autho…14:36 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Date of authorisation: 09/01/2020, Revision: 9, Status: Authorised14:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Date of authorisation: 09/01/2020, Revision: 9, Status: Authorised14:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tosmova (previously Tocilizumab STADA and Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 5, Status…14:30 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tosmova (previously Tocilizumab STADA and Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 5, Status…14:30 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised14:15 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 13, Status: Authorised14:15 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisa…13:36 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisa…13:36 UTC

INCIDENT EVOLUTION

3 recorded states

Oct 20 · 15:31 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 20 · 15:44 UTC

Headline updatedP2 · 99% quality · 2 sources

Oct 20 · 16:56 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →